蚊が媒介する病気の世界市場

蚊が媒介する病気の世界市場は2030年までに46億米ドルに達する見込み

2024年に32億米ドルと推定される蚊が媒介する病気の世界市場は、2024～2030年の分析期間においてCAGR 6.2%で成長し、2030年には46億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるマラリアは、CAGR 7.6%を記録し、分析期間終了時には15億米ドルに達すると予測されます。デング熱セグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は8億8,180万米ドルと推定、中国はCAGR 9.9％で成長予測

米国の蚊が媒介する病気市場は、2024年に8億8,180万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9億5,930万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と6.1%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界の蚊が媒介する病気市場- 主要動向と促進要因のまとめ

なぜ蚊が媒介する病気は依然として世界の健康危機なのか？

蚊が媒介する病気は、特に熱帯・亜熱帯地域において、世界的に公衆衛生上の大きな負担となり続けています。マラリア、デング熱、ジカウイルス、チクングニア、黄熱病、西ナイルウイルスなどの病気は、感染したイエネコ、アノフェレス、キュウリハムシに刺されることで感染します。これらの病原体は年間数百万人の感染を引き起こし、特に小児、高齢者、免疫不全者において大きな罹患率と死亡率をもたらしています。

予防や治療の進歩にもかかわらず、気候変動、都市化、森林伐採、世界の旅行などにより、蚊の生息地が拡大し、感染の可能性が広がっているため、蚊が媒介する病気は続いています。これらの疾患の多くは、特異的な抗ウイルス治療法や認可されたワクチンがないため、発生を食い止めるためには、総合的な媒介蚊の駆除、早期発見、公衆衛生教育が重要です。疾病媒介動物が以前は流行していなかった地域にまで拡大するにつれ、世界の脅威レベルは上昇の一途をたどっています。

どのような革新がサーベイランス、診断、ベクターコントロールを改善しているのか？

AIを活用したモデリング、リモートセンシング、GPSを活用したトラップネットワークなど、媒介蚊のサーベイランスにおける新たなアプローチは、蚊の個体数と発生リスクのリアルタイムモニタリングを向上させています。迅速診断検査（RDT）、マルチプレックスPCRプラットフォーム、バイオセンサーベースの検出システムは、特に遠隔地や資源の限られた環境において、ポイント・オブ・ケアレベルでより迅速かつ正確な診断を可能にしています。

ベクター対策では、無菌昆虫技術（SIT）、ウォルバキア感染蚊の放出、CRISPRベースの遺伝子ドライブなどの遺伝子工学技術が、蚊の繁殖力を低下させたり、病原体の感染を阻止するために試験されています。耐性の可能性が低い次世代殺虫剤、空間忌避剤、長持ちする殺虫ネット（LLINs）も導入されています。ワクチン開発パイプライン、特にデング熱、マラリア、ジカ熱の開発パイプラインは、後期臨床試験中または早期承認申請中の候補で進行中です。

どの地域と医療制度が疾病対策と介入への需要を牽引しているか？

サハラ以南のアフリカと東南アジアは、特にマラリアとデング熱に関して、依然として最も影響を受けている地域であり、ラテンアメリカ、カリブ海諸国、米国の一部では、ジカ熱とチクングニヤ熱の定期的な流行が見られます。公衆衛生機関、非政府組織（NGO）、国際保健連合は、流行地域における蚊の駆除プログラムや疾病サーベイランスの主要な推進役です。

高所得国では、気候の変化や旅行者の増加による蚊の再流行が、調査、緊急時対策、媒介蚊対策への投資に拍車をかけています。WHO、ゲイツ財団、Gaviなどの組織による国際的な資金援助は、ワクチンへのアクセス、研究開発、脆弱な人々における総合的な疾病管理の拡大に役立っています。衛生環境や水管理が不十分な都市部や半都市部は、依然として感染のホットゾーンであり、重点的に公衆衛生に介入する必要があります。

蚊が媒介する病気市場の成長はいくつかの要因によって牽引されている...

蚊が媒介する病気市場の成長は、世界の気温上昇、都市化の進展、蚊の増殖やウイルス感染を促進する旅行や貿易の拡大など、いくつかの要因によって牽引されています。診断技術、媒介蚊の駆除方法、遺伝子操作による解決策の進歩により、アウトブレイクを管理するためのツールセットが拡大しています。公衆衛生費、疾病撲滅プログラムへの国際援助、意識の高まりにより、ワクチン、媒介蚊モニタリングツール、殺虫剤製品に対する需要が高まっています。蚊が媒介する病気の地理的範囲が拡大し続ける中、流行地域と新たに感染した地域の両方において、統合的な予防、監視、治療戦略の必要性が加速しています。

セグメント

疾病タイプ（マラリア、デング熱、黄熱病、西ナイルウイルス、チクングニア、ジカウイルス、その他の疾病タイプ）、治療タイプ（投薬、ワクチン接種、ベクターコントロール法、免疫療法、支持療法、その他の治療タイプ）、エンドユーザー（病院、診療所、診断センター、研究機関、政府機関、NGO、その他のエンドユーザー）

調査対象企業の例（注目の34社）

• Abbott Laboratories
• Abnova Corporation
• Bayer AG
• BioCryst Pharmaceuticals Inc.
• Clarke Environmental Mosquito Management
• CSL Limited
• Eisai Co., Ltd.
• Emergent BioSolutions
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• InBios International Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Oxitec Ltd
• Pfizer Inc.
• Sanofi S.A.
• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Company Limited
• Vestergaard

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Mosquito Borne Diseases Market to Reach US$4.6 Billion by 2030

The global market for Mosquito Borne Diseases estimated at US$3.2 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Malaria, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Dengue segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$881.8 Million While China is Forecast to Grow at 9.9% CAGR

The Mosquito Borne Diseases market in the U.S. is estimated at US$881.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$959.3 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Mosquito Borne Diseases Market - Key Trends & Drivers Summarized

Why Are Mosquito Borne Diseases Still a Global Health Crisis?

Mosquito borne diseases continue to represent a significant global public health burden, particularly in tropical and subtropical regions. Diseases such as malaria, dengue fever, Zika virus, chikungunya, yellow fever, and West Nile virus are transmitted through the bites of infected Aedes, Anopheles, and Culex mosquitoes. These pathogens cause millions of infections annually and are responsible for substantial morbidity and mortality, particularly among children, the elderly, and immunocompromised individuals.

Despite advances in prevention and treatment, mosquito borne diseases persist due to climate change, urbanization, deforestation, and global travel-all of which expand mosquito habitats and transmission potential. Many of these diseases have no specific antiviral treatment or licensed vaccines, underscoring the importance of integrated vector control, early detection, and public health education in containing outbreaks. As disease vectors expand into previously non-endemic areas, the global threat level continues to rise.

What Innovations Are Improving Surveillance, Diagnosis, and Vector Control?

New approaches in vector surveillance, including AI-powered modeling, remote sensing, and GPS-enabled trap networks, are improving the real-time monitoring of mosquito populations and outbreak risks. Rapid diagnostic tests (RDTs), multiplex PCR platforms, and biosensor-based detection systems are enabling faster and more accurate diagnosis at point-of-care levels, particularly in remote and resource-limited settings.

In vector control, genetic engineering techniques such as sterile insect technology (SIT), Wolbachia-infected mosquito releases, and CRISPR-based gene drives are being tested to reduce mosquito fertility or block pathogen transmission. Next-generation insecticides with lower resistance potential, spatial repellents, and long-lasting insecticidal nets (LLINs) are also being deployed. Vaccine development pipelines-especially for dengue, malaria, and Zika-are progressing with candidates undergoing late-stage clinical trials or early regulatory approvals.

Which Regions and Health Systems Are Driving Demand for Disease Control and Intervention?

Sub-Saharan Africa and Southeast Asia remain the most affected regions, especially in relation to malaria and dengue, while Latin America, the Caribbean, and parts of the U.S. are seeing periodic outbreaks of Zika and chikungunya. Public health agencies, non-governmental organizations (NGOs), and global health alliances are key drivers of mosquito control programs and disease surveillance in endemic regions.

In high-income countries, the re-emergence of mosquito borne diseases due to climate shifts and increased travel is spurring investment in research, emergency preparedness, and vector control. International funding from organizations such as WHO, the Gates Foundation, and Gavi is helping expand vaccine access, R&D, and integrated disease management in vulnerable populations. Urban and semi-urban regions with inadequate sanitation and water management remain hot zones for transmission, necessitating focused public health interventions.

The Growth in the Mosquito Borne Diseases Market Is Driven by Several Factors…

The growth in the mosquito borne diseases market is driven by several factors including rising global temperatures, increased urbanization, and expanded travel and trade that facilitate mosquito proliferation and virus transmission. Advances in diagnostic technology, vector control methods, and genetically engineered solutions are expanding the toolset for managing outbreaks. Public health spending, international aid for disease elimination programs, and increased awareness are boosting demand for vaccines, vector monitoring tools, and insecticide products. As the geographic footprint of mosquito borne diseases continues to widen, the need for integrated prevention, surveillance, and therapeutic strategies is accelerating across both endemic and newly affected regions.

SCOPE OF STUDY:

The report analyzes the Mosquito Borne Diseases market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, Other Disease Types); Treatment Type (Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types); End-User (Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Abnova Corporation
• Bayer AG
• BioCryst Pharmaceuticals Inc.
• Clarke Environmental Mosquito Management
• CSL Limited
• Eisai Co., Ltd.
• Emergent BioSolutions
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• InBios International Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Oxitec Ltd
• Pfizer Inc.
• Sanofi S.A.
• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Company Limited
• Vestergaard

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Mosquito Borne Diseases - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Temperatures and Climate Change Expand Geographic Spread of Mosquito-Borne Diseases
  • Urbanization and Poor Sanitation in Emerging Markets Drive Risk of Disease Outbreaks
  • Increased Global Travel and Migration Strengthen Transmission Pathways for Vector-Borne Illnesses
  • OEM Focus on Rapid Diagnostic Tools and Surveillance Systems Enhances Early Detection and Response
  • Expansion of Public Health Campaigns Boosts Adoption of Preventive Measures and Insecticides
  • Development of Genetically Modified Mosquitoes and Biocontrol Technologies Offers New Disease Control Pathways
  • Push for Integrated Vector Management (IVM) Supports Multi-Pronged Public Health Interventions
  • Growth in Mosquito Net and Repellent Product Markets Strengthens Private Sector Engagement
  • Rising Government Investment in Vaccination Programs Supports Prevention of Dengue, Malaria, and Zika
  • Increased Incidence of Drug-Resistant Parasites Drives Demand for New Antiviral and Antiparasitic Treatments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Mosquito Borne Diseases Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Mosquito Borne Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Mosquito Borne Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Malaria by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Malaria by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Malaria by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Dengue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Dengue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Dengue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Yellow Fever by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Yellow Fever by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Yellow Fever by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for West Nile Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for West Nile Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for West Nile Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Chikungunya by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Chikungunya by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Chikungunya by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Zika Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Vector Control Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Vector Control Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Vector Control Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Supportive Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Supportive Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Supportive Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Government Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for NGOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for NGOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for NGOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 65: USA Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Mosquito Borne Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Mosquito Borne Diseases by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Rest of Europe Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Rest of Europe 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 177: Asia-Pacific Historic Review for Mosquito Borne Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Asia-Pacific Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 188: Australia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Australia Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Australia 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 191: Australia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Australia Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Australia 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 194: Australia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Australia Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Australia 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 197: India Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: India Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: India 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 200: India Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: India Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: India 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 203: India Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: India Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: India 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 206: South Korea Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: South Korea Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: South Korea 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 209: South Korea Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: South Korea Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: South Korea 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 212: South Korea Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: South Korea Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: South Korea 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Asia-Pacific Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Rest of Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 218: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Asia-Pacific Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Asia-Pacific Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Asia-Pacific 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 224: Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 225: Latin America Historic Review for Mosquito Borne Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Latin America 15-Year Perspective for Mosquito Borne Diseases by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 227: Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Latin America Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Latin America 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 230: Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Latin America Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Latin America 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 233: Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Latin America Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Latin America 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 236: Argentina Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Argentina Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Argentina 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 239: Argentina Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Argentina Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Argentina 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 242: Argentina Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Argentina Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Argentina 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 245: Brazil Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Brazil Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Brazil 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 248: Brazil Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Brazil Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Brazil 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 251: Brazil Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Brazil Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Brazil 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 254: Mexico Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Mexico Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Mexico 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 257: Mexico Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Mexico Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Mexico 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 260: Mexico Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Mexico Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Mexico 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Latin America Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Latin America 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Latin America Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Latin America 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Latin America Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Latin America Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Latin America 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 272: Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 273: Middle East Historic Review for Mosquito Borne Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Middle East 15-Year Perspective for Mosquito Borne Diseases by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 275: Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Middle East Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Middle East 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 278: Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Middle East Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Middle East 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 281: Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Middle East Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Middle East 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 284: Iran Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Iran Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Iran 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 287: Iran Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Iran Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Iran 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 290: Iran Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Iran Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Iran 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 293: Israel Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Israel Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Israel 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 296: Israel Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Israel Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Israel 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 299: Israel Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Israel Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Israel 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Saudi Arabia Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Saudi Arabia 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 305: Saudi Arabia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Saudi Arabia Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Saudi Arabia 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 308: Saudi Arabia Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Saudi Arabia Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Saudi Arabia 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 311: UAE Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: UAE Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: UAE 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 314: UAE Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: UAE Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: UAE 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 317: UAE Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: UAE Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: UAE 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Middle East Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Middle East 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Middle East Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Middle East 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Middle East Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Middle East Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Middle East 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Mosquito Borne Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 329: Africa Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Africa Historic Review for Mosquito Borne Diseases by Disease Type - Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Africa 15-Year Perspective for Mosquito Borne Diseases by Disease Type - Percentage Breakdown of Value Sales for Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 332: Africa Recent Past, Current & Future Analysis for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Africa Historic Review for Mosquito Borne Diseases by Treatment Type - Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Africa 15-Year Perspective for Mosquito Borne Diseases by Treatment Type - Percentage Breakdown of Value Sales for Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types, Medication and Vaccination for the Years 2015, 2025 & 2030
  • TABLE 335: Africa Recent Past, Current & Future Analysis for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Africa Historic Review for Mosquito Borne Diseases by End-user - Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Africa 15-Year Perspective for Mosquito Borne Diseases by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION